These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 36719370)

  • 41. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures.
    Vanderheiden A; Ralfs P; Chirkova T; Upadhyay AA; Zimmerman MG; Bedoya S; Aoued H; Tharp GM; Pellegrini KL; Manfredi C; Sorscher E; Mainou B; Lobby JL; Kohlmeier JE; Lowen AC; Shi PY; Menachery VD; Anderson LJ; Grakoui A; Bosinger SE; Suthar MS
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32699094
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.
    Chen LF; Yang CD; Cheng XB
    Front Immunol; 2021; 12():788368. PubMed ID: 35003106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. X-linked recessive TLR7 deficiency in ~1% of men under 60 years old with life-threatening COVID-19.
    Asano T; Boisson B; Onodi F; Matuozzo D; Moncada-Velez M; Maglorius Renkilaraj MRL; Zhang P; Meertens L; Bolze A; Materna M; Korniotis S; Gervais A; Talouarn E; Bigio B; Seeleuthner Y; Bilguvar K; Zhang Y; Neehus AL; Ogishi M; Pelham SJ; Le Voyer T; Rosain J; Philippot Q; Soler-Palacín P; Colobran R; Martin-Nalda A; Rivière JG; Tandjaoui-Lambiotte Y; Chaïbi K; Shahrooei M; Darazam IA; Olyaei NA; Mansouri D; Hatipoğlu N; Palabiyik F; Ozcelik T; Novelli G; Novelli A; Casari G; Aiuti A; Carrera P; Bondesan S; Barzaghi F; Rovere-Querini P; Tresoldi C; Franco JL; Rojas J; Reyes LF; Bustos IG; Arias AA; Morelle G; Christèle K; Troya J; Planas-Serra L; Schlüter A; Gut M; Pujol A; Allende LM; Rodriguez-Gallego C; Flores C; Cabrera-Marante O; Pleguezuelo DE; de Diego RP; Keles S; Aytekin G; Akcan OM; Bryceson YT; Bergman P; Brodin P; Smole D; Smith CIE; Norlin AC; Campbell TM; Covill LE; Hammarström L; Pan-Hammarström Q; Abolhassani H; Mane S; Marr N; Ata M; Al Ali F; Khan T; Spaan AN; Dalgard CL; Bonfanti P; Biondi A; Tubiana S; Burdet C; Nussbaum R; Kahn-Kirby A; Snow AL; ; ; ; ; ; ; ; ; ; Bustamante J; Puel A; Boisson-Dupuis S; Zhang SY; Béziat V; Lifton RP; Bastard P; Notarangelo LD; Abel L; Su HC; Jouanguy E; Amara A; Soumelis V; Cobat A; Zhang Q; Casanova JL
    Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34413140
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19.
    Parums DV
    Med Sci Monit; 2021 Sep; 27():e934766. PubMed ID: 34538868
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examination of autoantibodies to type I interferon in patients suffering from long COVID.
    Hansen KS; Jørgensen SE; Skouboe MK; Agergaard J; Schiøttz-Christensen B; Vibholm LK; Tolstrup M; Østergaard L; Leth S; Mogensen TH
    J Med Virol; 2023 Sep; 95(9):e29089. PubMed ID: 37698062
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon at the crossroads of SARS-CoV-2 infection and COVID-19 disease.
    Samuel CE
    J Biol Chem; 2023 Aug; 299(8):104960. PubMed ID: 37364688
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Autoantibodies against type I IFNs in patients with critical influenza pneumonia.
    Zhang Q; Pizzorno A; Miorin L; Bastard P; Gervais A; Le Voyer T; Bizien L; Manry J; Rosain J; Philippot Q; Goavec K; Padey B; Cupic A; Laurent E; Saker K; Vanker M; Särekannu K; ; ; ; ; ; ; ; García-Salum T; Ferres M; Le Corre N; Sánchez-Céspedes J; Balsera-Manzanero M; Carratala J; Retamar-Gentil P; Abelenda-Alonso G; Valiente A; Tiberghien P; Zins M; Debette S; Meyts I; Haerynck F; Castagnoli R; Notarangelo LD; Gonzalez-Granado LI; Dominguez-Pinilla N; Andreakos E; Triantafyllia V; Rodríguez-Gallego C; Solé-Violán J; Ruiz-Hernandez JJ; Rodríguez de Castro F; Ferreres J; Briones M; Wauters J; Vanderbeke L; Feys S; Kuo CY; Lei WT; Ku CL; Tal G; Etzioni A; Hanna S; Fournet T; Casalegno JS; Queromes G; Argaud L; Javouhey E; Rosa-Calatrava M; Cordero E; Aydillo T; Medina RA; Kisand K; Puel A; Jouanguy E; Abel L; Cobat A; Trouillet-Assant S; García-Sastre A; Casanova JL
    J Exp Med; 2022 Nov; 219(11):. PubMed ID: 36112363
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients.
    Ferré EMN; Schmitt MM; Ochoa S; Rosen LB; Shaw ER; Burbelo PD; Stoddard JL; Rampertaap S; DiMaggio T; Bergerson JRE; Rosenzweig SD; Notarangelo LD; Holland SM; Lionakis MS
    Front Immunol; 2021; 12():720205. PubMed ID: 34504497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Severe COVID-19 represents an undiagnosed primary immunodeficiency in a high proportion of infected individuals.
    Gray PE; Bartlett AW; Tangye SG
    Clin Transl Immunology; 2022; 11(4):e1365. PubMed ID: 35444807
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs.
    Lopez J; Mommert M; Mouton W; Pizzorno A; Brengel-Pesce K; Mezidi M; Villard M; Lina B; Richard JC; Fassier JB; Cheynet V; Padey B; Duliere V; Julien T; Paul S; Bastard P; Belot A; Bal A; Casanova JL; Rosa-Calatrava M; Morfin F; Walzer T; Trouillet-Assant S
    J Exp Med; 2021 Oct; 218(10):. PubMed ID: 34357402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Auto-antibodies to type I IFNs can underlie adverse reactions to yellow fever live attenuated vaccine.
    Bastard P; Michailidis E; Hoffmann HH; Chbihi M; Le Voyer T; Rosain J; Philippot Q; Seeleuthner Y; Gervais A; Materna M; de Oliveira PMN; Maia MLS; Dinis Ano Bom AP; Azamor T; Araújo da Conceição D; Goudouris E; Homma A; Slesak G; Schäfer J; Pulendran B; Miller JD; Huits R; Yang R; Rosen LB; Bizien L; Lorenzo L; Chrabieh M; Erazo LV; Rozenberg F; Jeljeli MM; Béziat V; Holland SM; Cobat A; Notarangelo LD; Su HC; Ahmed R; Puel A; Zhang SY; Abel L; Seligman SJ; Zhang Q; MacDonald MR; Jouanguy E; Rice CM; Casanova JL
    J Exp Med; 2021 Apr; 218(4):. PubMed ID: 33544838
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of Genetic or Cellular Impairments in Type I IFN Immunity in a Cohort of Young Adults with Critical COVID-19.
    Covill LE; Sendel A; Campbell TM; Piiroinen I; Enoksson SL; Borgström EW; Hansen S; Ma K; Marits P; Norlin AC; Smith CIE; Kåhlin J; Eriksson LI; Bergman P; Bryceson YT
    J Clin Immunol; 2024 Jan; 44(2):50. PubMed ID: 38231281
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neutralizing type-I interferon autoantibodies are associated with delayed viral clearance and intensive care unit admission in patients with COVID-19.
    Abers MS; Rosen LB; Delmonte OM; Shaw E; Bastard P; Imberti L; Quaresima V; Biondi A; Bonfanti P; Castagnoli R; Casanova JL; Su HC; Notarangelo LD; Holland SM; Lionakis MS
    Immunol Cell Biol; 2021 Oct; 99(9):917-921. PubMed ID: 34309902
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies.
    Damoiseaux J; Dotan A; Fritzler MJ; Bogdanos DP; Meroni PL; Roggenbuck D; Goldman M; Landegren N; Bastard P; Shoenfeld Y; Conrad K
    Autoimmun Rev; 2022 Mar; 21(3):103012. PubMed ID: 34896650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Autoantibodies neutralizing type I IFNs are present in
    Bastard P; Gervais A; Le Voyer T; Rosain J; Philippot Q; Manry J; Michailidis E; Hoffmann HH; Eto S; Garcia-Prat M; Bizien L; Parra-Martínez A; Yang R; Haljasmägi L; Migaud M; Särekannu K; Maslovskaja J; de Prost N; Tandjaoui-Lambiotte Y; Luyt CE; Amador-Borrero B; Gaudet A; Poissy J; Morel P; Richard P; Cognasse F; Troya J; Trouillet-Assant S; Belot A; Saker K; Garçon P; Rivière JG; Lagier JC; Gentile S; Rosen LB; Shaw E; Morio T; Tanaka J; Dalmau D; Tharaux PL; Sene D; Stepanian A; Megarbane B; Triantafyllia V; Fekkar A; Heath JR; Franco JL; Anaya JM; Solé-Violán J; Imberti L; Biondi A; Bonfanti P; Castagnoli R; Delmonte OM; Zhang Y; Snow AL; Holland SM; Biggs C; Moncada-Vélez M; Arias AA; Lorenzo L; Boucherit S; Coulibaly B; Anglicheau D; Planas AM; Haerynck F; Duvlis S; Nussbaum RL; Ozcelik T; Keles S; Bousfiha AA; El Bakkouri J; Ramirez-Santana C; Paul S; Pan-Hammarström Q; Hammarström L; Dupont A; Kurolap A; Metz CN; Aiuti A; Casari G; Lampasona V; Ciceri F; Barreiros LA; Dominguez-Garrido E; Vidigal M; Zatz M; van de Beek D; Sahanic S; Tancevski I; Stepanovskyy Y; Boyarchuk O; Nukui Y; Tsumura M; Vidaur L; Tangye SG; Burrel S; Duffy D; Quintana-Murci L; Klocperk A; Kann NY; Shcherbina A; Lau YL; Leung D; Coulongeat M; Marlet J; Koning R; Reyes LF; Chauvineau-Grenier A; Venet F; Monneret G; Nussenzweig MC; Arrestier R; Boudhabhay I; Baris-Feldman H; Hagin D; Wauters J; Meyts I; Dyer AH; Kennelly SP; Bourke NM; Halwani R; Sharif-Askari NS; Dorgham K; Sallette J; Sedkaoui SM; AlKhater S; Rigo-Bonnin R; Morandeira F; Roussel L; Vinh DC; Ostrowski SR; Condino-Neto A; Prando C; Bonradenko A; Spaan AN; Gilardin L; Fellay J; Lyonnet S; Bilguvar K; Lifton RP; Mane S; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; Anderson MS; Boisson B; Béziat V; Zhang SY; Vandreakos E; Hermine O; Pujol A; Peterson P; Mogensen TH; Rowen L; Mond J; Debette S; de Lamballerie X; Duval X; Mentré F; Zins M; Soler-Palacin P; Colobran R; Gorochov G; Solanich X; Susen S; Martinez-Picado J; Raoult D; Vasse M; Gregersen PK; Piemonti L; Rodríguez-Gallego C; Notarangelo LD; Su HC; Kisand K; Okada S; Puel A; Jouanguy E; Rice CM; Tiberghien P; Zhang Q; Cobat A; Abel L; Casanova JL
    Sci Immunol; 2021 Aug; 6(62):. PubMed ID: 34413139
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity.
    Tangye SG; Bucciol G; Meyts I
    Curr Opin Allergy Clin Immunol; 2021 Dec; 21(6):515-524. PubMed ID: 34494617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. X-Linked TLR7 Deficiency Underlies Critical COVID-19 Pneumonia in a Male Patient with Ataxia-Telangiectasia.
    Abolhassani H; Vosughimotlagh A; Asano T; Landegren N; Boisson B; Delavari S; Bastard P; Aranda-Guillén M; Wang Y; Zuo F; Sardh F; Marcotte H; Du L; Zhang SY; Zhang Q; Rezaei N; Kämpe O; Casanova JL; Hammarström L; Pan-Hammarström Q
    J Clin Immunol; 2022 Jan; 42(1):1-9. PubMed ID: 34686943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1.
    Meager A; Visvalingam K; Peterson P; Möll K; Murumägi A; Krohn K; Eskelin P; Perheentupa J; Husebye E; Kadota Y; Willcox N
    PLoS Med; 2006 Jul; 3(7):e289. PubMed ID: 16784312
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α.
    Mathian A; Breillat P; Dorgham K; Bastard P; Charre C; Lhote R; Quentric P; Moyon Q; Mariaggi AA; Mouries-Martin S; Mellot C; Anna F; Haroche J; Cohen-Aubart F; Sterlin D; Zahr N; Gervais A; Le Voyer T; Bizien L; Amiot Q; Pha M; Hié M; Chasset F; Yssel H; Miyara M; Charneau P; Ghillani-Dalbin P; Casanova JL; Rozenberg F; Amoura Z; Gorochov G
    Ann Rheum Dis; 2022 Dec; 81(12):1695-1703. PubMed ID: 35973806
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased Sensitivity of SARS-CoV-2 to Type III Interferon in Human Intestinal Epithelial Cells.
    Metz-Zumaran C; Kee C; Doldan P; Guo C; Stanifer ML; Boulant S
    J Virol; 2022 Apr; 96(7):e0170521. PubMed ID: 35262371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.